Klebsiella pneumoniae
Carbapenemaseproducing Enterobacteria in Hospital, Singapore
To the Editor: During the past decade, enterobacteria that produce Klebsiella pneumoniae carbapenemase (KPC) have become established in the United States and countries in South America and Europe (1) . In Asia, KPC was reported in the People's Republic of China in 2007 (2) and subsequently in South Korea (3) and Taiwan (4) . Public health agencies emphasize screening and strict contact precautions to control multidrug resistant Enterobacteriaceae (5) . Routine testing for mechanisms of resistance facilitates detection of emerging carbapenem-resistant Enterobacteriaceae.
In Singapore's 1,000-bed National University Hospital during November 2010-January 2011, we identifi ed New Delhi metallo-β-lactamase 1-producing Enterobacteriaceae in 2 clinical specimens but none that produced KPC (I. Venkatachalam et al., unpub. data). We conducted a laboratory screening study to determine the prevalence and nature of carbapenem-resistant Enterobacteriaceae in April 2011. Ethics committee approval was waived for this study.
Testing of rectal swab samples is part of an established hospitalwide program for vancomycin-resistant enterococci screening. Using a scoring system to identify patients at high risk for vancomycin-resistant enterococci (6), we found that ≈2.5 specimens per 100 admissions were attained each month. During our study, we also tested these samples for carbapenemaseproducing Enterobacteriaceae.
During April-June 2011, we incubated specimens for 24 h in 10 mL tryptic soy broth containing 1 mg/L imipenem, then streaked 100 μL of the broth onto CHROMagar KPC (CHROMagar, Paris, France). Colonies detected after 24 h incubation at 35°C were identifi ed by using MALDI-TOF MS with a Microfl ex LT instrument (Bruker Daltonik GmbH, Leipzig, Germany). Imipenem and meropenem MICs for Enterobacteriacaeae were confi rmed by using Etests (bioMérieux, Marcy l'Etoile, France). Isolates with MIC >2 μg/mL underwent analysis with Metallo-β-Lactamase Confi rmative Identifi cation Pack (Rosco Diagnostica, Taastrup, Denmark) and Etest MBL (bioMérieux) for metallo-β-lactamase production. Isolates suspected to be producers were genotypically confi rmed by PCR.
Of the 201 nonduplicate samples processed, 79 microorganisms exhibited imipenem resistance and were isolated on CHROMagar KPC (Table) . Among Enterobacteriaceae, carbapenem MIC >2 μg/mL was present in 1 E. aerogenes, 2 E. cloacae, and 4 K. pneumoniae isolates. One isolate (K. pneumoniae) had a positive combined disk test result with a pattern suggestive of serine carbapenemase production.
We analyzed genomic DNA (DNeasy Blood and Tissue Kit, QIAGEN, Hilden, Germany) from this isolate by using PCR for transmissible carbapenem resistance markers: metallo-β-lactamases (VIM, IMP, and KHM-1), serine carbapenemases (KPC, GES1-5 and 7), and OXA-48. bla KPC -specifi c primers (for-ward primer 5′-CGTTGACGCCCAAT CC-3′; reverse primer 5′-ACCGCT GGCAGCTGG-3′) generated a 390-bp amplicon. Full gene sequencing of bla KPC (forward primer 5′-ATGTCAC TGTATCGCCGTCT-3′; reverse primer 5 ′ -CCTAAATGTGACAGTGGT TGG) revealed 100% homology to bla KPC-2 (GenBank accession no. FJ628167.2). Further analysis showed that the isolate carried extended-spectrum β-lactamase (bla TEM-1 , bla SHV-11 , bla CTX-M-15 ), plasmid-located AmpC (bla DHA-1 ), and 16S rRNA methylase armA genes but was negative for bla CMY , bla OXA , bla GES , metallo-β-lactamases, and plasmidmediated quinolone (qnr) genes. Multilocus sequence typing conducted at Institut Pasteur (Paris, France), identifi ed this isolate as sequence type 11. It was susceptible only to colistin and tigecycline.
Sequence type 11, a singlelocus variant of the internationally dominant sequence type 258 clone (7), is present in 64.2% of KPC-producing K. pneumoniae in China (8) . In South Korea, sequence type 11 is the most common clone of extendedspectrum β-lactamase-producing K. pneumoniae isolates (3).
The KPC-producing K. pneumoniae originated from a woman in the local community, 89 years of age, who had severe ischemic cardiomyopathy and atrial fi brillation. She was discharged home after a 3-day hospitalization for treatment of stroke in January 2011. During May 2011, she was readmitted after a severe stroke. During week 4, she was transferred to a subacute care hospital but readmitted within 24 hours with a lower respiratory tract infection. A rectal swab sample was collected for routine screening for vancomycin-resistant enterococci.
We empirically prescribed a 10-day course of piperacillin-tazobactam. On day 10 of treatment, KPC-producing K. pneumoniae was isolated from the rectal specimen. The patient responded to treatment and was discharged to a long-term care facility. This case demonstrates concerns about a KPC of local community origin because no other KPCproducing Enterobacteriaceae were isolated during this inpatient surveillance and the patient had neither received antimicrobial drugs nor traveled in the 6 months before her May admission (7). However, she was admitted 3 weeks before sampling; an unidentifi ed hospital source remains a possibility. Of added concern is the potential for dissemination within the facility to which she was discharged.
Resistance To the Editor: The bla NDM-1 gene, which produces the New Delhi metallo-β-lactamase (NDM-1) enzyme, confers resistance to the carbapenem class of antimicrobial drugs and can be transferred among different types of bacteria. NDM-1 was identifi ed in 2008 in Sweden from a patient from India who had been hospitalized in New Delhi (1) . Since that report, bla NDM-1 -positive bacteria have been identifi ed from patients in several countries; most of these patients had a direct link with the Indian subcontinent (2). The spread of bla NDM-1 among bacterial pathogens is of concern not only because of resistance to carbapenems but also because such pathogens typically are resistant to multiple antimicrobial drug classes, which leaves few treatment choices available (3) (4) (5) . In 2011, spread of bla NDM-1 -positive bacteria in an environmental setting in New Delhi was reported (6) .
The possible appearance of bacteria harboring bla NDM-1 in Vietnam is of concern because cultural and economic links between Vietnam and India are strongly established, including extensive person-to-person exchanges that could enable easy exchange of pathogens. In addition, Vietnam faces a serious problem of antimicrobial drug resistance because drugs are freely available and used in an indiscriminate fashion. Thus, once bla NDM-1 -positive bacteria colonize persons in Vietnam, they would be able to spread easily and pose a serious public health threat.
During September 2011, we collected paired swab samples (1 for PCR, 1 for culture) of seepage water from 20 sites (rivers, lakes, and water pools in streets) within a 10-km radius of central Hanoi, Vietnam. Samples were transported in Transystem (CO-PAN Italia S.p.A, Brescia, Italy) to preserve bacteria and DNA. The 20 PCR swab specimens were squeezed out into 0.5-mL volumes of sterile water and centrifuged at 3,000 × g for 30 seconds; 1 μL of the resulting suspension was then used as PCR template to detect bla NDM-1 as described (7) . Two samples were positive for bla NDM-1 ; these 2 samples were collected from the same river (Kim Nguu River) but at sites 3 km apart.
To isolate and identify the phenotype and genotype of bla NDM-1 -positive bacteria, we repeatedly spread the 20 culture swab specimens onto MullerHinton agar (Nissui, Tokyo, Japan) containing 100 mg/L vancomycin (Nakalai, Kyoto, Japan) plus 0.5 mg/L meropenem (LKT Laboratories, St. Paul, MN, USA) until single colonies were obtained. Each colony was then subcultured by plating onto MacConkey agar (Nihon Seiyaku, Tokyo, Japan) containing 0.5 mg/L meropenem to ensure culture purity; colonies were identifi ed by using API 20E strips (bioMérieux, Basingstoke, UK). MICs of these isolates for 13 antimicrobial drugs were calculated by using Etest (bioMérieux), and susceptibility data were interpreted by using Clinical and Laboratory Standards Institute guidelines (www.clsi.org).
We harvested several species of bacteria from the 2 seepage samples positive for bla NDM-1 : Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, P. fl uorescens/putida, and P. luteola. These isolates were placed onto media containing 0.5 mg/L meropenem, and bacterial DNA was extracted and used for the template for PCR analysis to detect bla NDM-1 as described (7) . bla NDM-1 was detected in 3 K. pneumoniae isolates from each of the 2 positive samples (6 isolates total); this result was confi rmed by sequencing. All 6 isolates were highly resistant to all β-lactam antimicrobial drugs, including carbapenems (Table) . To
